<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(11)</volume><submitter>Pepin D</submitter><pubmed_abstract>Human tissue kallikreins (KLKs) are members of a multigene family of serine proteases aberrantly expressed in many cancer types. In ovarian cancer, 12 KLKs are upregulated, and of those KLK5, 6 and 10 have been the focus of investigations into new diagnostic and prognostic biomarkers. However, little is known about the contributions of KLK5, 6 and 10 to ovarian cancer pathophysiology.In this study, a panel of 13 human ovarian cancer cell lines was screened by ELISA for secretion of KLK5, 6, 8, 10, 13, and 14. The ES-2 cell line, devoid of these kallikreins, was transfected with expression vectors of KLK5, 6 and 10 individually or in pairs. Co-expression of KLK5, 6 and 10 was correlated with lessened aggressivity of ovarian cancer cell lines as defined by reduced colony formation in soft ag</pubmed_abstract><journal>PloS one</journal><pagination>e26075</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3216928</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model.</pubmed_title><pmcid>PMC3216928</pmcid><pubmed_authors>Pepin D</pubmed_authors><pubmed_authors>Shao ZQ</pubmed_authors><pubmed_authors>Vanderhyden BC</pubmed_authors><pubmed_authors>Chu CW</pubmed_authors><pubmed_authors>Huppe G</pubmed_authors><pubmed_authors>Sharif Z</pubmed_authors><pubmed_authors>Wakefield A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model.</name><description>Human tissue kallikreins (KLKs) are members of a multigene family of serine proteases aberrantly expressed in many cancer types. In ovarian cancer, 12 KLKs are upregulated, and of those KLK5, 6 and 10 have been the focus of investigations into new diagnostic and prognostic biomarkers. However, little is known about the contributions of KLK5, 6 and 10 to ovarian cancer pathophysiology.In this study, a panel of 13 human ovarian cancer cell lines was screened by ELISA for secretion of KLK5, 6, 8, 10, 13, and 14. The ES-2 cell line, devoid of these kallikreins, was transfected with expression vectors of KLK5, 6 and 10 individually or in pairs. Co-expression of KLK5, 6 and 10 was correlated with lessened aggressivity of ovarian cancer cell lines as defined by reduced colony formation in soft ag</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011</publication><modification>2025-07-09T03:05:03.567Z</modification><creation>2025-07-09T03:05:03.567Z</creation></dates><accession>S-EPMC3216928</accession><cross_references><pubmed>22102857</pubmed><doi>10.1371/journal.pone.0026075</doi></cross_references></HashMap>